BioCentury
ARTICLE | Clinical News

Ushercell: Began Phase I testing

May 10, 1999 7:00 AM UTC

Polydex Pharmaceuticals Ltd. (POLXF), Toronto, Ontario Product: Ushercell Business: Infectious diseases, Reproductive Therapeutic category: Viral infection Target: Viral lipid coats and the acrosome c...